Pharmaceutical Technology

DECEMBER 21, 2022

Artificial intelligence (AI) continued to stay in the news with several high-profile deals this year, as the pharmaceutical industry readily took to adopting AI models to improve drug discovery. This could spell high-stake consequences for consumers whose privacy and safety could be at risk if AI models are not regulated.

Pharma 140

Pharma Medicine Pharmaceutical Government 140

European Pharmaceutical Review

SEPTEMBER 22, 2023

Limitations of monoclonal antibody therapies Regulatory approvals from the US Food and Drug Administration (FDA) for aducanumab and lecanemab – and likely very soon for donanemab also – opened a route for different therapeutic modalities and other relevant disease targets, such as tau.

Food and Drug Administration 77

Food and Drug Administration Safety Patients Leads 77

Pharmaceutical Technology

MARCH 6, 2023

Whether one refers to such research as “longevity”, “anti-aging” or “extending healthspan”, it is clear this area has evolved massively over the last few years with more scientists now eager to get drugs in this area from bench to bedside. What is aging clinical research? Such issues may have caused hesitance in some drug regulators.

FDA 145

FDA Pharmaceutical Prospecting Medicine 145

Pharmaceutical Technology

APRIL 12, 2023

Pharmaceutical research has long relied on non-human primate models for early-stage discoveries, but their use continues to cause controversy. However, according to the US Food and Drug Administration (FDA), non-human primates are still the most scientifically relevant large model to test biologic drugs for safety.

Pharma 98

Pharma Food and Drug Administration Safety Medicine 98